| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 03/08/2005 | US6864355 Inhibition of NF-κB activation by blockade of IKKβ-NEMO interactions at the NEMO binding domain |
| 03/08/2005 | US6864282 9,11-cycloendoperoxide pro-drugs of prostaglandin analogues for treatment of ocular hypertension and glaucoma |
| 03/08/2005 | US6864277 Brain diosrders; cardiovascular disorders; central nervous system disorders; psychological disorders |
| 03/08/2005 | US6864252 Treatment of cyclooxygenase mediated diseases, such as arthritis, neurodegeneration and colon cancer |
| 03/08/2005 | US6864243 Method for treating retinal degeneration with purinergic receptor agonists |
| 03/08/2005 | US6864239 Methods and compounds for prevention and treatment of elevated intraocular pressure and related conditions |
| 03/03/2005 | WO2005019245A1 Heptadepsin |
| 03/03/2005 | WO2005018672A1 Drug containing chymase inhibitor as the active ingredient |
| 03/03/2005 | WO2005018646A1 Ophthalmic composition |
| 03/03/2005 | WO2005018634A1 The use of the hernatoporphyrin monomethyl ether for the treatment of the eye disorders |
| 03/03/2005 | WO2005018608A1 Drug delivery system for sub-tenon’s capsule administration of fine grains |
| 03/03/2005 | WO2004112830A3 Clostridial toxins for treating eye disorders |
| 03/03/2005 | WO2004108764A3 Connective tissue growth factor antibodies |
| 03/03/2005 | WO2004001058A3 Transcription factor modulating compounds and methods of use thereof |
| 03/03/2005 | US20050049424 6-Hydroxy isoflavones derivatives and medicaments involving same |
| 03/03/2005 | US20050049261 Substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido{1,2-a}pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo{1,2-a}pyrimidin-5(1h)one derivatives |
| 03/03/2005 | US20050049259 Viricides; for the prophylaxis and treatment of herpes viral infections |
| 03/03/2005 | US20050049251 Inhibitors of p38 |
| 03/03/2005 | US20050049246 Such as [3-(2-Bromo-ethoxy)-phenyl]-[4-(3-cyclohexyl-5-methyl-isoxazol-4-yl)-pyrimidin-2-yl]-amine |
| 03/03/2005 | US20050049233 Transdermal administering of testosterone |
| 03/03/2005 | US20050049227 Cyclohexyl prostaglandin analogs as EP4-receptor agonists |
| 03/03/2005 | US20050049189 Immunosuppressive protein for use in treatment and prevention of allergic, autoimmune, skin and respiratory disorders |
| 03/03/2005 | US20050048639 Caspase-8 binding protein, its preparation and use |
| 03/03/2005 | US20050048528 Using immunoglobulins and diagnostic and/or prognostic tool for detection and treatment of cell proliferative disorders; immunodiagnostics; immunotherapy |
| 03/03/2005 | US20050048488 Expression vector comprising nucleotide sequences coding excitatory amino acid transporter 2 (EAAT2) proteins for use in identifying modulator for treatment and preention of neurological or psychiatric disorder |
| 03/03/2005 | US20050048479 Adenylyl and guanylyl cyclases |
| 03/03/2005 | US20050048137 Extract of plant dendrobii caulis and preparing process thereof |
| 03/03/2005 | US20050048055 Use of CD40 engagement to alter T cell receptor usage |
| 03/03/2005 | US20050048044 Controlling, adjustment diffusion or degradation of membrane using activating energy source such as light source or ultraviolet radiation |
| 03/03/2005 | US20050048035 Methods of using regenerative cells in the treatment of stroke and related diseases and disorders |
| 03/03/2005 | US20050048034 Using adipose stem cells to treat ischemic ulcer, diabetic and traumatic wounds; regenerative medicine |
| 03/03/2005 | US20050047958 Methods for sterilizing preparations of digestive enzymes |
| 03/03/2005 | CA2536435A1 Drug containing chymase inhibitor as the active ingredient |
| 03/03/2005 | CA2535516A1 Silencing of tgf-beta receptor type ii expression by sirna |
| 03/02/2005 | EP1510519A1 Pharmaceutical compositions comprising 2,3-diarylpyrazolo[1,5-B]pyridazine derivatives |
| 03/02/2005 | EP1510221A1 Preventives and/or remedies for subjects with the expression or activation of her2 and/or egfr |
| 03/02/2005 | EP1510218A1 Extract of plant dendrobii caulis and preparing process thereof |
| 03/02/2005 | EP1510137A1 Pyruvate enriched onion extract |
| 03/02/2005 | EP1509532A1 1-thia-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 03/02/2005 | EP1509528A2 1,3-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 03/02/2005 | EP1509526A2 Imidazo(1,2-a)pyrazin-8-ylamines, method of making, and method of use thereof |
| 03/02/2005 | EP1509524A1 Xanthine phosphodiesterase v inhibitor polymorphs |
| 03/02/2005 | EP1509506A1 Pyridazine derivatives |
| 03/02/2005 | EP1509489A1 Amines that inhibit a mammalian anandamide transporter, and methods of use thereof |
| 03/02/2005 | EP1509251A2 Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 03/02/2005 | EP1509237A2 Methods of treating angiogenesis, tumor growth, and metastasis |
| 03/02/2005 | EP1509233A1 Liquid formulation of decitabine and use of the same |
| 03/02/2005 | EP1509188A2 Compounds active at the glucocorticoid receptor ii |
| 03/02/2005 | EP1278741B1 Muscarinic agonists |
| 03/02/2005 | EP1244649B1 Cyclic amp-specific phosphodiesterase inhibitors |
| 03/02/2005 | EP1135105B1 Use of a neurologic agent for the manufacture of a medicament for the treatment of a central nervous system disorder |
| 03/02/2005 | EP1014976B1 Novel substituted imidazole compounds |
| 03/02/2005 | EP0868186B1 Use of certain isoquinolinesulfonyl compounds for the treatment of glaucoma and ocular ischemia |
| 03/02/2005 | EP0824530B1 Aryl glycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds |
| 03/02/2005 | CN1589269A Heteroindanes: a new class of potent cannabimimetic ligands |
| 03/02/2005 | CN1589261A Piperidine derivatives and their use as modulators of chemokine receptor activity (especially CCR5) |
| 03/02/2005 | CN1589260A Heterocyclic compounds and methods of use thereof |
| 03/02/2005 | CN1589151A Diagnostic or therapeutic somatostatin or bombesin analog conjugates and uses thereof |
| 03/02/2005 | CN1589145A αv整联蛋白受体拮抗剂 αv integrin receptor antagonists |
| 03/02/2005 | CN1589144A Use of an ascomycin for the treatment of blepharitis |
| 03/02/2005 | CN1587269A Medicinal composition containing angiotensin II receptor antagonist and vitamin B |
| 03/02/2005 | CN1586499A Calf blood deproteinizing extract, its eye ointment preparation and its preparing method |
| 03/02/2005 | CN1586486A Cefpodoxime proxetil soft capsule preparation and its preparing method |
| 03/02/2005 | CN1191362C Streptococcus antigens |
| 03/02/2005 | CN1191276C Humanized antibodies and method for forming same |
| 03/02/2005 | CN1191246C Indolylpiperidine derivatives as antihistaminic and antiallergic agents |
| 03/02/2005 | CN1191077C Soluble granules for curing vitreous opacity and hemorrhage and preparation method thereof |
| 03/02/2005 | CN1191074C Bear bile powder eye drop and its prepn |
| 03/02/2005 | CN1191069C Otic microbial combinations medicine |
| 03/02/2005 | CN1191062C Medicinal compositions |
| 03/01/2005 | US6861429 2,3-diaryl-pyrazolo[1,5-b]pyridazines derivatives, their preparation and their use as cyclooxygenase 2 (COX-2) inhibitors |
| 03/01/2005 | US6861425 Benzimidazole compounds as ORL1-receptor agonists |
| 03/01/2005 | US6861417 Such as 2-(4-fluorophenyl)-3-(pyridin-4-yl)pyrazine for treating cytokine mediated diseases such as psoriatic arthritis |
| 03/01/2005 | US6861399 Cleaning compositions containing human serine protease T |
| 03/01/2005 | US6861056 Applying composition comprising interferon gamma antibodies topically to eye to treat hyperimmune reactions such as transplant rejection, uveitis, autoimmune diseases of eye |
| 02/24/2005 | WO2004087195A3 Therapeutic use of modulators of notch and/or kruppel-like factors |
| 02/24/2005 | WO2004069258A3 Use of the sgk gene family for diagnosis and therapy of cataracts and glaucoma |
| 02/24/2005 | US20050043412 Remedies for glaucoma comprising bunazosin and prostaglandins |
| 02/24/2005 | US20050043410 Using an epinephrine type compound; controlling neovascularization |
| 02/24/2005 | US20050043399 Dimeric compounds and their use as anti-viral agents |
| 02/24/2005 | US20050043383 Combined agents for treatment of glaucoma |
| 02/24/2005 | US20050043362 Use of compounds |
| 02/24/2005 | US20050043349 1-Alkyl-1-azoniabicyclo' 2.2.!octane carbamate derivatives and their use as muscarinic receptor antagonists |
| 02/24/2005 | US20050043344 Such as 3-(3,5-ditert-butylphenyl)-4-{3-[3-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)propyl]-1,2,4-oxadiazol-5-yl}butanoic acid; for treatment of tumor metastasis, angiogenesis, osteoporosis, arthritis, retinopathy, smooth muscle cell migration, restenosis, and atheroscelorosis |
| 02/24/2005 | US20050043332 Such as 4 (cis-3-hydroxycyclopentyl)amino-5,6-dimethyl-2-phenyl-7H-pyrrolo[2,3d] pyrimidine for treatment of adenosine receptor stimulated diseases, cardiovascular disorders, and nervous system disorders |
| 02/24/2005 | US20050043305 Aryl substituted pyridines, pyrimidines, pyrazines and triazines and the use thereof |
| 02/24/2005 | US20050043304 Lower alkyl molecular weight amine as enzyme inhibitors for use in the treatment of tryptase enzyme inhibitors inhibitorsfor respiratory system disorders, antiinflammatory agents, inflammatory bowel disease, hyperprolific skin disorders, vascular edema and rheumatoid arthritis |
| 02/24/2005 | US20050043286 Use of an ascomycin for the treatment of blepharitis |
| 02/24/2005 | US20050043271 Heparin-containing ophthalmic agent |
| 02/24/2005 | US20050043214 Antiglaucomatous agent and use thereof |
| 02/24/2005 | US20050042738 Carbohydrate-associated proteins |
| 02/24/2005 | US20050042731 Four helical bundle cytokine family polypeptide for use in treatment, diagnosis and prevention of infection, cardiovascular, metabolic, developmental, skin, bone, inflammatory and autoimmune disorders |
| 02/24/2005 | US20050042671 Modulation of angiogenesis |
| 02/24/2005 | US20050042614 Point mutations; dipeptidyl-peptidase inhibitors; kits |
| 02/24/2005 | US20050042317 Complex mixtures exhibiting selective inhibition of cyclooxygenase-2 |
| 02/24/2005 | US20050042299 Use of milk serum apoproteins in the prophylaxis or treatment of microbial or viral infection |
| 02/24/2005 | US20050042243 Oat extracts: refining, compositions and methods of use |
| 02/24/2005 | US20050042201 Synergistic mixture of glycoprotein and angiogenesis inhibitor comprising angiostatin, thrombostatin, endostatin, interferon, interferon-inducible factor 10, platelet factor, and/or cyclooxygenase inhibitor; antitumor and anticarcinogenic agents |
| 02/23/2005 | EP1508570A1 Novel physiolgically active substances |
| 02/23/2005 | EP1507866A2 Carotene synthase gene and uses therefor |